Locations:
Search IconSearch

Image of Note: 3-D Radiation-Free Navigation of the Aorta

Endovascular navigation technology clears first preclinical study

Centerline Biomedical IOPS

Endovascular repair of aortic aneurysms and dissections is critically dependent on optimal understanding of the patient’s vasculature. To that end, Cleveland Clinic Innovations spinoff company Centerline Biomedical Inc. is refining development of its Intraoperative Positioning System (IOPS), a novel endovascular navigation technology developed by Cleveland Clinic researchers.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

IOPS extracts the centerlines of the aorta and branch vessels from a patient’s CT and then mathematically constructs a high-quality three-dimensional model of the relevant vasculature, as shown in the image above. Electromagnetic tracking technology allows the model to be used in a GPS-like fashion to guide surgeons during minimally invasive endovascular aortic repairs, enabling less reliance on X-ray fluoroscopy.

The first preclinical in vivo study of IOPS was completed in May 2016 at Cleveland Clinic Lerner Research Institute. It demonstrated the system’s ability to provide non-radiation-based navigation with superior visualization compared with X-ray fluoroscopy, which is limited by its two-dimensional visualization and by the radiation exposure it confers on patients and providers.

“Preclinical evaluation verified the ability to use this navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy,” says Cleveland Clinic vascular surgeon Matthew Eagleton, MD, who led the study. Noting that catheters and guidewires were easily visualized on the IOPS display, he predicted that the system “will be a game changer in the era of endovascular therapy.”

Centerline Biomedical plans to submit IOPS for FDA review, with a target market entry in the third quarter of 2017.

Advertisement

Related Articles

Tricuspid valve after transcatheter replacement

Who Should Be Performing Transcatheter Tricuspid Interventions?

Consensus statement outlines the team, infrastructure and experience needed to deliver TTVI safely and effectively

illustrated human heart with several sutured parts

A ‘Semi-Inclusion’ Modification of the Ross Procedure Delivers Durable Clinical Success

Innovative approach to living-tissue AVR achieves low reintervention rates, excellent long-term survival

thin arm of a woman grasping the side of a hospital bed mattress

AHA Statement Targets Undernutrition in Inpatients With Acute Cardiac Conditions

Diagnosis and treatment of malnutrition and cachexia are key to improving cardiac outcomes

surgical team operating below monitors in an operating room

Benefits of Myectomy for Obstructive HCM Are Greatest at Earlier Symptomatic Stages

Symptom burden at presentation is a potent predictor of long-term survival, large analysis shows

clot in a lung passageway with an arrow pointing at it

Guideline for Acute Pulmonary Embolism Offers More Nuanced Risk Stratification

New framework better distinguishes stable from critically ill patients

six panels of black-and-white heart imaging studies grouped in a rectangle

AI System Combines Images With Written Impressions to Accurately Read Cardiac MRI

CMR-CLIP outperforms general AI tools; may one day expand patient access to CMR

illustrated platelets forming a clot in a blood vessel

Bempedoic Acid Appears to Curb VTE Risk in Statin-Intolerant Patients

Post hoc analysis of CLEAR Outcomes trial bolsters its case as a statin alternative

female hands holding a pharmaceutical injector

GLP-1 RAs Show Survival and Cardiovascular Benefits in Patients With HFrEF and Diabetes

Large retrospective analysis may prompt prospective studies

Ad